Cara Therapeutics | CARA - Fremdkapital

Aktienkurs
3.39
Täglich Wechseln
0.17 5.28%
Monatlich
-1.45%
Jährlich
-80.60%
Q2 Prognose
2.82




Fremdkapital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Assertio Holdings USD 39.17M 120K 2025-09
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Chugai Pharma JPY 4.53B 1.95B 2024-12
Cipla INR 2.98B 454.6M 2025-09
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Grifols EUR 9.95B 722.93M 2025-12
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
J&J USD 39.44B 30M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pacira USD 372.19M 4.53M 2025-12
Pfizer USD 57.41B 93M 2025-09
RedHill Biopharma USD 190K 0 2024-06
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12